Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells

References

• Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, et al. Trends and patterns of disparities in cancer mortality among US counties, 1980-2014. JAMA. 2017;317(4):388–406. doi:10.1001/jama.2016.2032428118455
   PubMed Web of Science ®Google Scholar
• Supit W, Mochtar CA, Sugiono M, Umbas R. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review. Asian Pac J Cancer P. 2011;12(2):549–553.
   PubMedGoogle Scholar
• van Rhijn BWG, Burger M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009;56(3):430–442. doi:10.1016/j.eururo.2009.06.02819576682
   PubMed Web of Science ®Google Scholar
• Chamie K, Litwin MS, Bassett JC, et al. Recurrence of high-risk bladder cancer: A population-based analysis. Cancer-Am Cancer Soc. 2013;119(17):3219–3227.
   Google Scholar
• Chaffer CL, Marjanovic ND, Lee T, et al. Poised chromatin at the ZEB1 Promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell. 2013;154(1):61–74. doi:10.1016/j.cell.2013.06.00523827675
   PubMed Web of Science ®Google Scholar
• Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438–1449. doi:10.1038/nm.333624202396
   PubMed Web of Science ®Google Scholar
• Li LN, Li WL. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacol Therapeut. 2015;150:33–46. doi:10.1016/j.pharmthera.2015.01.004
   PubMed Web of Science ®Google Scholar
• Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293–299. doi:10.1111/j.1349-7006.2009.01419.x19961486
   PubMed Web of Science ®Google Scholar
• Rout-Pitt N, Farrow N, Parsons D, Donnelley M. Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Resp Res. 2018;19(1):136–146. doi:10.1186/s12931-018-0834-8.
   Web of Science ®Google Scholar
• Mrkvicova A, Chmelarova M, Peterova E, et al. The effect of sodium butyrate and cisplatin on expression of EMT markers. PLoS One. 2019;14(1):e0210889. doi:10.1371/journal.pone.021088930653577
   PubMed Web of Science ®Google Scholar
• Zeng B, Lin ZW, Ye HL, et al. Upregulation of LncDQ is associated with poor prognosis and promotes tumor progression via epigenetic regulation of the EMT pathway in HCC. Cell Physiol Biochem. 2018;46(3):1122–1133. doi:10.1159/00048884129669339
   PubMedGoogle Scholar
• Li MY, Liu JQ, Chen DP, et al. p68 prompts the epithelial-mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF-β1 signaling pathway. Oncol Lett. 2018;15(2):2111–2116. doi:10.3892/ol.2017.755229434913
   PubMed Web of Science ®Google Scholar
• Xu SH, Huang JZ, Xu ML, et al. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. J Pathol. 2015;236(2):175–185. doi:10.1002/path.451525678401
   PubMed Web of Science ®Google Scholar
• Zheng H, Shen M, Zha YL, et al. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell. 2014;26(3):358–373. doi:10.1016/j.ccr.2014.07.02225203322
   PubMed Web of Science ®Google Scholar
• Hui W, Jiaolong S, Yuhao L, et al. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. Clin Cancer Res. 2014;20(22):5835–5847. doi:10.1158/1078-0432.CCR-14-048525252758
   PubMed Web of Science ®Google Scholar
• Yokobori T, Nishiyama M. TGF-Î2 signaling in gastrointestinal cancers: progress in basic and clinical research. J Clin Med Res. 2017;6(1):11. doi:10.3390/jcm6010011
   Google Scholar
• Sato T, Muramatsu T, Tanabe M, Inazawa J. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line. Cancer Sci. 2018;109(11):3623–3633. doi:10.1111/cas.1378330156359
   PubMed Web of Science ®Google Scholar
• Bissey PA, Law JH, Bruce JP, et al. Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma. Oncogenesis. 2018;7(5):40. doi:10.1038/s41389-018-0050-x29795279
   PubMedGoogle Scholar
• Guo SK, Shen MF, Yao HW, Liu YS. Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells. Cell Physiol Biochem. 2018;49(3):1138–1150. doi:10.1159/000493293
   Google Scholar
• Yoo HJ, Yun BR, Kwon JH, et al. Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. Exp Mol Med. 2009;41(2):102–115. doi:10.3858/emm.2009.41.2.01319287191
   PubMed Web of Science ®Google Scholar
• Zou J, Huang RY, Jiang FN, et al. Overexpression of TPX2 is associated with progression and prognosis of prostate cancer. Oncol Lett. 2018;16(3):2823–2832. doi:10.3892/ol.2018.901630127868
   PubMed Web of Science ®Google Scholar
• Bronsert P, Enderle-Ammour K, Bader M, et al. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol. 2014;234(3):410–422. doi:10.1002/path.441625081610
   PubMed Web of Science ®Google Scholar
• Skonier J, Bennett K, Rothwell V, et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol. 1994;13(6):571–584. doi:10.1089/dna.1994.13.5718024701
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Yu CP, Li YH, Jiang LJ, Zhou FJ. Utility of SAM68 in the progression and prognosis for bladder cancer. BMC Cancer. 2015;15:36425944080
   PubMed Web of Science ®Google Scholar
• Joan M. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616–630. doi:10.1038/nrm343422992590
   PubMed Web of Science ®Google Scholar
• Heldina CH, Moustakas A. Regulation of EMT by TGFβ in cancer. FEBS Lett. 2012;586(14):1959–1970. doi:10.1016/j.febslet.2012.02.03722710176
   PubMed Web of Science ®Google Scholar
• Skonier J, Neubauer M, Madisen L, Bennett K, GD P, AF P. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992;11(7):511–522. doi:10.1089/dna.1992.11.5111388724
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wen GG, Wang C, et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2009;69(1):37–44. doi:10.1158/0008-5472.CAN-08-164819117985
   PubMed Web of Science ®Google Scholar
• Han B, Cai H, Chen Y, et al. The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis. Mol Cancer. 2015;14(1):64. doi:10.1186/s12943-014-0278-925889002
   PubMedGoogle Scholar
• Andrei T, Davide M, Yinghong W, et al. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. J Proteome Res. 2011;10(9):4302–4313. doi:10.1021/pr200527z21755970
   PubMed Web of Science ®Google Scholar
• Buckhaults P, Rago C, St Croix B, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 2001;61(19):6996–7001.11585723
   PubMed Web of Science ®Google Scholar
• Choi SI, Kim BY, Dadakhujaev S, et al. Impaired autophagy and delayed autophagic clearance of transforming growth factor β-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy. 2012;8(12):1782–1797. doi:10.4161/auto.2206722995918
   PubMed Web of Science ®Google Scholar
• Dominik A, Mirjam B, Daniel Stephan E, Hans-Peter S. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol. 2013;20(7):651–660. doi:10.1111/iju.1211323387805
   PubMed Web of Science ®Google Scholar
• Isabel F, Joan F, Jessica M, Patricia S. TGF-beta signaling in cancer treatment. Curr Pharm Des. 2014;20(17):2934–2947. doi:10.2174/13816128113199990591
   Web of Science ®Google Scholar
• Ikushima H, Miyazono K. TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β. Cell Tissue Res. 2012;347(1):37–49. doi:10.1007/s00441-011-1179-521618142
   PubMed Web of Science ®Google Scholar